Sep 13, 2021 / 07:30PM GMT
Albert Hwang;Morgan Stanley;Managing Director -
Good afternoon, everybody, and thank you for joining Day 3 or Monday of the Morgan Stanley Global Healthcare Conference.
With me, I have Emergent. And before we get started, I'm going to read a quick disclaimer. For important disclosures, please see the Morgan Stanley Research Disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So again, thanks for joining this fireside chat. I'm Albert Hwang. I'm a Managing Director and Co-Head of the U.S. Healthcare Group at Morgan Stanley in the Investment Banking division. And maybe what I'll do is turn it over to Rich Lindahl, the CFO of Emergent, to introduce the team. And perhaps, Rich, just to kick us off, you can give a 5-minute overview and update on what's going on at Emergent.
Richard S. Lindahl - Emergent BioSolutions Inc. - Executive VP, CFO & Treasurer
Great. Yes. Thanks, Albert. I appreciate it. And thank you, everyone,
Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers